54.26
price up icon0.84%   0.45
after-market Dopo l'orario di chiusura: 56.25 1.99 +3.67%
loading
Precedente Chiudi:
$53.81
Aprire:
$54.8
Volume 24 ore:
1.49M
Relative Volume:
0.64
Capitalizzazione di mercato:
$10.37B
Reddito:
$217.77M
Utile/perdita netta:
$-438.86M
Rapporto P/E:
-22.51
EPS:
-2.41
Flusso di cassa netto:
$-456.33M
1 W Prestazione:
-1.20%
1M Prestazione:
+7.13%
6M Prestazione:
+50.89%
1 anno Prestazione:
+124.49%
Intervallo 1D:
Value
$54.23
$55.56
Intervallo di 1 settimana:
Value
$52.75
$56.50
Portata 52W:
Value
$21.72
$57.49

Bridgebio Pharma Inc Stock (BBIO) Company Profile

Name
Nome
Bridgebio Pharma Inc
Name
Telefono
(650) 391-9740
Name
Indirizzo
3160 PORTER DR., PALO ALTO, CA
Name
Dipendente
730
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
BBIO's Discussions on Twitter

Confronta BBIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
BBIO
Bridgebio Pharma Inc
54.26 10.29B 217.77M -438.86M -456.33M -2.41
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

Bridgebio Pharma Inc Stock (BBIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-30 Ripresa Raymond James Outperform
2025-07-21 Iniziato Truist Buy
2025-07-14 Iniziato Jefferies Buy
2025-07-09 Aggiornamento Oppenheimer Perform → Outperform
2025-06-17 Iniziato Wolfe Research Outperform
2025-03-31 Iniziato Redburn Atlantic Buy
2024-10-16 Iniziato Scotiabank Sector Outperform
2024-10-03 Iniziato Oppenheimer Perform
2024-09-04 Iniziato Piper Sandler Overweight
2024-03-21 Ripresa Raymond James Outperform
2024-01-31 Iniziato BMO Capital Markets Market Perform
2023-12-08 Iniziato Wells Fargo Overweight
2023-11-07 Iniziato Citigroup Buy
2023-10-24 Iniziato Cantor Fitzgerald Overweight
2023-07-18 Downgrade Jefferies Buy → Hold
2023-04-19 Iniziato Evercore ISI Outperform
2023-02-06 Iniziato Cowen Outperform
2021-12-27 Reiterato Mizuho Buy
2021-12-27 Reiterato SVB Leerink Outperform
2021-09-10 Aggiornamento BofA Securities Neutral → Buy
2021-05-21 Iniziato UBS Buy
2021-03-22 Reiterato Goldman Buy
2021-02-22 Ripresa JP Morgan Overweight
2021-02-09 Ripresa Goldman Buy
2021-01-11 Reiterato H.C. Wainwright Buy
2020-12-10 Reiterato H.C. Wainwright Buy
2020-06-25 Iniziato BofA/Merrill Neutral
2020-05-19 Iniziato BTIG Research Buy
2020-04-13 Iniziato H.C. Wainwright Buy
2020-02-19 Iniziato Mizuho Buy
2019-07-26 Iniziato Raymond James Outperform
2019-07-22 Iniziato BMO Capital Markets Outperform
2019-07-22 Iniziato Goldman Buy
2019-07-22 Iniziato JP Morgan Overweight
2019-07-22 Iniziato Jefferies Buy
2019-07-22 Iniziato Piper Jaffray Overweight
2019-07-22 Iniziato SVB Leerink Outperform
Mostra tutto

Bridgebio Pharma Inc Borsa (BBIO) Ultime notizie

pulisher
02:58 AM

Real time alert setup for BridgeBio Pharma Inc. performanceWeekly Trend Summary & Low Risk High Win Rate Stock Picks - newser.com

02:58 AM
pulisher
01:18 AM

Will BridgeBio Pharma Inc. stock pay special dividendsEarnings Summary Report & Free AI Powered Buy and Sell Recommendations - newser.com

01:18 AM
pulisher
12:57 PM

How BridgeBio Pharma Inc. (2CL) stock reacts to fiscal policiesExit Point & Low Drawdown Trading Strategies - newser.com

12:57 PM
pulisher
04:42 AM

What indicators show strength in BridgeBio Pharma Inc.Fed Meeting & Real-Time Chart Pattern Alerts - newser.com

04:42 AM
pulisher
03:20 AM

Why retail investors favor BridgeBio Pharma Inc. stock2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - newser.com

03:20 AM
pulisher
Oct 24, 2025

BridgeBio to Report Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study, along with Third Quarter 2025 Financial Results Next Week - The Manila Times

Oct 24, 2025
pulisher
Oct 24, 2025

BridgeBio (NASDAQ: BBIO) to present FORTIFY interim topline Oct. 27; earnings Oct. 29 - Stock Titan

Oct 24, 2025
pulisher
Oct 24, 2025

Is BridgeBio Pharma Inc. stock supported by strong fundamentalsJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com

Oct 24, 2025
pulisher
Oct 23, 2025

Will BridgeBio Pharma Inc. (2CL) stock outperform value peersQuarterly Trade Review & Entry and Exit Point Strategies - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

What analysts say about BridgeBio Pharma Inc stockStop Loss Placement Tips & Small Investment Capital Tips - earlytimes.in

Oct 22, 2025
pulisher
Oct 22, 2025

Sentiment analysis tools applied to BridgeBio Pharma Inc.2025 Support & Resistance & Fast Gain Swing Alerts - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

BridgeBio Pharma Inc. stock trend outlook and recovery path2025 Technical Patterns & Entry and Exit Point Strategies - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Leading vs lagging indicators on BridgeBio Pharma Inc. performance2025 AllTime Highs & Daily Volume Surge Signals - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Long term hold vs stop loss in BridgeBio Pharma Inc.July 2025 Retail & Free High Return Stock Watch Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Using economic indicators to assess BridgeBio Pharma Inc. potentialChart Signals & Weekly High Return Stock Opportunities - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

BridgeBio Pharma stock rating reiterated as Overweight by Wells Fargo - Investing.com Canada

Oct 20, 2025
pulisher
Oct 20, 2025

BridgeBio (BBIO) Tanks After Selling Beyonttra Royalty Rights - MSN

Oct 20, 2025

Bridgebio Pharma Inc Azioni (BBIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
Capitalizzazione:     |  Volume (24 ore):